6286-46-0

Basic information

• Product Name: 2-BROMO-4,5-DIMETHOXYBENZOIC ACID
• Synonyms: 2-BROMO-4,5-DIMETHOXYBENZOIC ACID;6-BROMOVERATRIC ACID;6-BROMO-3,4-DIMETHOXYBENZOIC ACID;RARECHEM AL BE 0015;2-Bromo-4,5-dimethoxybenzoic acid,97%;Nsc10074;441074_ALDRICH;Benzoic acid, 2-bromo-4,5-dimethoxy-
• CAS NO: 6286-46-0
• Molecular Formula: C₉H₉BrO₄
• Molecular Weight: 261.07
• Product Categories: Aromatic Carboxylic Acids, Amides, Anilides, Anhydrides & Salts;Aromatics Compounds;Aromatics
• Mol File: 6286-46-0.mol
• Article Data: 18

Chemical Properties

• Melting Point: 188-190 °C(lit.)
• Boiling Point: 337.6 °C at 760 mmHg
• Flash Point: 158 °C
• Appearance: White to cream or yellow/Powder
• Density: 1.571 g/cm³
• Vapor Pressure: 4.05E-05mmHg at 25°C
• Refractive Index: 1.566
• Storage Temp.: Room temperature.
• Solubility: Chloroform (Slightly), Methanol (Slightly)
• PKA: 3.00±0.10(Predicted)
• CAS DataBase Reference: 2-BROMO-4,5-DIMETHOXYBENZOIC ACID(CAS DataBase Reference)
• NIST Chemistry Reference: 2-BROMO-4,5-DIMETHOXYBENZOIC ACID(6286-46-0)
• EPA Substance Registry System: 2-BROMO-4,5-DIMETHOXYBENZOIC ACID(6286-46-0)

Safety Data

• Hazard Codes: Xi
• Statements: 36/37/38
• Safety Statements: 26-36
• WGK Germany: 3
• HazardClass: IRRITANT
• Hazardous Substances Data: 6286-46-0(Hazardous Substances Data)

Usage

Chemical Properties

Off-White Crystalline Solid

Uses

2-Bromo-4,5-dimethoxybenzoic acid may be used as starting material for the synthesis of norathyriol and urolithins.

General Description

2-Bromo-4,5-dimethoxybenzoic acid is a 2-halo-4,5-dialkoxybenzoic acid derivative.

InChI:InChI=1/C9H9BrO4/c1-13-7-3-5(9(11)12)6(10)4-8(7)14-2/h3-4H,1-2H3,(H,11,12)

Upstream product

• 93-07-2 Veratric acid 
• 110-86-1 pyridine 
• 67-66-3 chloroform 
• 58262-60-5 2,3',4,4',6-pentamethoxybenzophenone 
• 7726-95-6 bromine 
• 52806-46-9 1-bromo-4,5-dimethoxy-2-methylbenzene 
• 494-99-5 1,2-dimethoxy-4-methylbenzene 
• 26759-46-6 methyl 2-amino-4,5-dimethoxybenzoate 
• 109305-98-8 2-bromo-4,5-dimethoxybenzonitrile 
• 17667-32-2 methyl 6-bromo-3,4-dimethoxybenzoate 
• 619-04-5 3,4-dimethylbenzoic acid 
• 120-14-9 3,4-dimethoxy-benzaldehyde 
• 26791-93-5 methyl 4,5-dimethoxy-2-nitrobenzoate 
• 60632-40-8 6-bromovanillin 

Downstream Products

• 51072-66-3 1-bromo-4,5-dimethoxy-2-nitro-benzene 
• 121936-68-3 2-bromo-5-hydroxy-4-methoxybenzoic acid 
• 121031-19-4 benzyl 2-bromo-4,5-dimethoxybenzoate 
• 170709-79-2 (E)-N-(3',4'-dimethoxystyryl)-2-bromo-4,5-dimethoxybenzamide 
• 35491-92-0 1-(2-Chloro-ethyl)-2-chloromethyl-4,5-dimethoxy-benzene 
• 67645-12-9 2-Hydroxymethyl-4,5-dimethoxy-phenylaethylalkohol 
• 68204-77-3 4,5-dimethoxy-2-methoxycarbonylmethyl-benzoic acid methyl ester 
• 95151-82-9 (β-chloroethyl-2 dimethoxy-4,5 benzyl) methylphosphinate d'ethyle 
• 2859-78-1 4-Bromoveratrole 
• 42833-49-8 2,3-dimethoxy-9H-xanthen-9-one 
• 1384436-55-8 2-bromo-2'-hydroxy-4,5,4',6'-tetramethoxyl benzophenone 
• 5722-93-0 2-hydroxy-4,5-dimethoxybenzoic acid 
• 877997-98-3 2-hydroxy-4,5-dimethoxybenzoic acid phenyl ester 
• 877997-99-4 2-[(2-hydroxy-4,5-dimethoxybenzoyl)amino]-1,3-thiazole-4-carboxylic acid methyl ester 

Relevant articles and documents

Synthesis of 4-ethyl-5-methyl-5,6-dihydrophenanthridine-8,9-diol as the key intermediate of potent agonists of the Wnt signalling pathway

The synthesis of 4-ethyl-5-methyl-5,6-dihydro-phenanthridine-8,9-diol as the key intermediate of a series of potent Wnt signalling pathway agonists is reported. This synthesis features a consecutive aryl-aryl and N-aryl coupling, leading to 4-ethyl-5-meth

COMPOUND FOR TREATMENT OR PREVENTION OF OBESITY OR DISEASES RELATED TO OBESITY, AND APPLICATION THEREOF

A compound for treatment or prevention of obesity or diseases related to obesity, and an application thereof. Specifically, provided are a compound as represented by formula I, or a pharmaceutically-acceptable salt thereof, and a pharmaceutical compositio

METHOD FOR PRODUCING 2-HALOGENATED BENZOIC ACIDS

The purpose of the present invention is to provide a method for producing 2-halogenated benzoic acids, the method imparting high regioselectivity (high selectivity) and having a shorter reaction time than does the conventional reaction. This method for producing 2-halogenated benzoic acids, in order to achieve the above purpose, is characterized in that benzoic acids and a halogenating agent are reacted in the presence of an alkaline compound, making it possible to highly selectively obtain 2-halogenated benzoic acids.